METHYL LAURATE
Relevant Data
Food Additives Approved by WHO:
Flavouring Substances Approved by European Union:
General Information
| Mainterm | METHYL LAURATE |
| Doc Type | ASP |
| CAS Reg.No.(or other ID) | 111-82-0 |
| Regnum |
172.515 |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 8139 |
| IUPAC Name | methyl dodecanoate |
| InChI | InChI=1S/C13H26O2/c1-3-4-5-6-7-8-9-10-11-12-13(14)15-2/h3-12H2,1-2H3 |
| InChI Key | UQDUPQYQJKYHQI-UHFFFAOYSA-N |
| Canonical SMILES | CCCCCCCCCCCC(=O)OC |
| Molecular Formula | C13H26O2 |
| Wikipedia | methyl laurate |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 214.349 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 11 |
| Complexity | 144.0 |
| CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A C A C A g A I C C A A A B A A I A A C Q C A A A A A A A A A A A A A E A A A A A A B I A A A A A A A A E A A A A A A G I y K C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
| Topological Polar Surface Area | 26.3 |
| Monoisotopic Mass | 214.193 |
| Exact Mass | 214.193 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 15 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.9848 |
| Human Intestinal Absorption | HIA+ | 0.9881 |
| Caco-2 Permeability | Caco2+ | 0.8141 |
| P-glycoprotein Substrate | Non-substrate | 0.7061 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8951 |
| Non-inhibitor | 0.7988 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8908 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.4276 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8648 |
| CYP450 2D6 Substrate | Non-substrate | 0.8885 |
| CYP450 3A4 Substrate | Non-substrate | 0.6454 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5548 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9329 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9502 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9524 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9773 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9176 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9104 |
| Non-inhibitor | 0.8787 | |
| AMES Toxicity | Non AMES toxic | 0.9765 |
| Carcinogens | Carcinogens | 0.5347 |
| Fish Toxicity | High FHMT | 0.8790 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8990 |
| Honey Bee Toxicity | High HBT | 0.7623 |
| Biodegradation | Ready biodegradable | 0.8747 |
| Acute Oral Toxicity | III | 0.8589 |
| Carcinogenicity (Three-class) | Non-required | 0.7269 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -3.3987 | LogS |
| Caco-2 Permeability | 1.2386 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 1.4915 | LD50, mol/kg |
| Fish Toxicity | 0.8236 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.6648 | pIGC50, ug/L |
From admetSAR
Toxicity Profile
| Route of Exposure | |
|---|---|
| Mechanism of Toxicity | |
| Metabolism | |
| Toxicity Values | |
| Lethal Dose | |
| Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
| Minimum Risk Level | |
| Health Effects | |
| Treatment | |
| Reference |
|
From T3DB
Taxonomic Classification
| Kingdom | Organic compounds |
|---|---|
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Subclass | Fatty acid esters |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Fatty acid methyl esters |
| Alternative Parents | |
| Molecular Framework | Aliphatic acyclic compounds |
| Substituents | Fatty acid methyl ester - Methyl ester - Carboxylic acid ester - Monocarboxylic acid or derivatives - Carboxylic acid derivative - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Carbonyl group - Aliphatic acyclic compound |
| Description | This compound belongs to the class of organic compounds known as fatty acid methyl esters. These are compounds containing a fatty acid that is esterified with a methyl group. They have the general structure RC(=O)OR', where R=fatty aliphatic tail or organyl group and R'=methyl group. |
From ClassyFire
Targets
- General Function:
- Zinc ion binding
- Specific Function:
- Ligand-activated transcription factor. Receptor for bile acids such as chenodeoxycholic acid, lithocholic acid and deoxycholic acid. Represses the transcription of the cholesterol 7-alpha-hydroxylase gene (CYP7A1) through the induction of NR0B2 or FGF19 expression, via two distinct mechanisms. Activates the intestinal bile acid-binding protein (IBABP). Activates the transcription of bile salt export pump ABCB11 by directly recruiting histone methyltransferase CARM1 to this locus.
- Gene Name:
- NR1H4
- Uniprot ID:
- Q96RI1
- Molecular Weight:
- 55913.915 Da
References
- Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]
From T3DB